Beyond Air, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three
Beyond Air, Inc. (XAIR) had Lessee, Operating Lease, Liability, to be Paid, Year Three of $309.00 thousand as of 2026-03-31, per its 10-K filed 2026-06-26.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2026-06-26
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $309.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $402.00K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $451.00K.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $551.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three |
|---|---|
| 2026-03-31 | $309.00K 10-K · filed 2026-06-26 |
| 2025-03-31 | $402.00K 10-K · filed 2025-06-20 |
| 2024-03-31 | $451.00K 10-K · filed 2024-06-24 |
| 2023-03-31 | $551.00K 10-K · filed 2023-06-22 |
| 2022-03-31 | $434.00K 10-K · filed 2022-06-29 |
| 2021-12-31 | $437.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $277.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $277.45K 10-Q · filed 2021-08-10 |
| 2020-03-31 | $64.69K 10-K · filed 2020-06-23 |
| 2019-12-31 | $64.83K 10-Q · filed 2020-02-07 |
| 2019-09-30 | $64.83K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $64.83K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |